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1. Introduction 
It is generally recognized that histidine-12 plays a 
direct role in the mechanism of action of ribonuclease 
A. Thanks to the S-peptide/S-protein system of 
Richards [l] it has been possible to study the func- 
tion of the imidazole-12 moiety in the enzymatic 
reaction by preparing RNase S’ analogues in which 
histidine-12 is replaced by other residues. 
Replacement of L-histidine- 12 by the isosteric 
P-pyrazolyl-3-Lalanine [2] or 4-fluoro-Lhistidine 
[3], both having a p@s of 2.5, results in complete 
loss of catalytic activity, whereas the binding to S- 
protein remains practically unaffected. These findings 
demonstrate the influence of the pK!Jn on the catalytic 
efficiency (pKp His 6.0). Recently we reported a 
remarkably high activity of a RNase S’ analogue in 
which His-l 2 is replaced by Lhomohistidine [4,5] , 
that suggestively has almost the same p@ value as 
histidine. The binding capacity of this S-peptide 
analogue is lowered by a factor of approximately 
100 relative to S-peptide l-20, indicating the influence 
of lengthening the side chain. 
We now wish to report an extension of the investiga- 
*Part XIX in the series Studies on Polypeptides; preceding 
publication on RNase S’ analogues: see reference [ 51. 
Abbreviations: RNase A, bovine pancreatic ribonuclease; 
RNase S, native ribonuclease cleaved by subtilisin; the 
resulting active complex can be separated into its two 
inactive components: S-peptide and S-protein. RNase S’, 
the reconstituted active complex obtained by mixing equi- 
molar amounts of S-peptide and S-protein. 
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tions on the topochemistry of the active site, con- 
sisting of the synthesis of an S-peptide analogue in 
which the side chain of His-l 2 is shortened by one 
carbon atom. The capacity of this peptide to combine 
with S-protein and ribonucleic acid, and the reactivity 
of the resulting complex is discussed. 
2. Experimental 
DL4-Imidazolylglycine (abbreviated as Nhi) was 
synthesized according to the procedure described by 
Schneider [6]. Although L-Cimidazolylglycine can 
be easily obtained by optical resolution (acylase I) of 
the DLcompound, the diastereoisomers racemize 
within several hours under acid as well as alkaline con- 
ditions [7]. For that reason it has not much sense to 
incorporate just one of these isomers into a peptide. 
One should keep in mind that without a special analysis 
the ratio of the two products, one with the L and the 
other with the D-imidazolylglycine, can only be 
guessed at. 
t-Butyloxycarbonyl-DL-4Gmidazolylglycine (Boc- 
Nhi-OH) was prepared in essentially the same way as 
described for the synthesis of Boc-histidine [8] ; during 
the reaction with Boc-azide the reaction mixture was 
kept at pH 10 with 4 N LiOH. Conversion of the di- 
Boc- into the mono-Boc-derivative was accomplished 
in MeOH under stirring for 48 hours. After evaporation 
to dryness Hz0 was added and the aqueous solution 
was brought to pH 3 with 2 N HCl. The acid solution 
was extracted with n-butanol (four times) and the 
combined extracts were partially evaporated in vacua to 
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remove Hz0 azeotropically, resulting in a spontaneous 
crystallisation of Boc-Nhi-OH. After filtration crystals 
were dried (paraffin cuttings) in vacua at 40°C. Yield 
83%; m.p. 186-I 88 “C. Homogeneous (P’, RH*) on 
TLC (Rr 0.62 in MeOH), when dissolved in a LiOH 
solution. The nmr-spectrum (DMSO-d6) was con- 
sistent with the structure; 6-values relative to TMS: 
(CHa)aC at S = 1.4 (s); o-CH at 6 = 5.1 (d); n-CH at 
6 = 7.1 (s); r-CH at 6 = 7.6 (s); NH at 6 = 7:O (d). A 
satisfactory elemental analysis was obtained 
(CIOHI~NJ~; C,H,N,G). 
(Nhi’*)-RNase S-peptide l-14 was synthesized by 
the solid-phase method [9] as described previously 
for the synthesis of other S-peptide analogues [5], 
starting from 1.5 g of Boc-Asp(OBzl)-resin (0.32 mmol 
of Boc-Asp (OBzl)-OH per g of Boc-Asp (OBzl)-resin). 
Boc-Nhi-OH (5eq) was completely coupled within 
four hours with DCC (5eq) and HOBt (5eq) in DMF. 
After synthesis and purification a yield of 30 mg 
was obtained. Homogeneous on paper electrophoresis 
(pH 4.8 and 6.5) and paper chromatography (Rf 0.70 X 
His in BAPW 15 : 3: 10: 12). An acid hydrolysate 
showed Lys 1.91 (‘1 Glu 3.26c3), Thr 0.96(r), Ala 
2.98c3), Phe 0.91(l), Arg 1.00(l), Nhi 1.07(l), Met 
1.03(l), Asp 1.07(l), using Nle as an internal standard; 
peptide content 70%. 
The S-protein activating ability of this S-peptide 
analogue was determined according to the method of 
Berger and Levit [ 10,l 1] . For further experimental 
details see reference [5]. 
3. Results and discussion 
Figure 1 shows the activity (change in transmittance/ 
min) of the complex formed when varying amounts of 
(Nhi”)-RNase S-peptide l-14 are mixed with a con- 
stant amount of S-protein (5 X lo-’ M), using yeast 
RNA (from BDH, purified by the procedure of Klee 
and Richards [ 121) as a substrate. The S-peptide 
analogue could not be tested at concentrations higher 
than 2 X 1 0w4 M under the given assay conditions, due 
to solubility problems. The highest measured activity 
was approximately 20% relative to that of RNase S’. 
peptide concentration x 10’ [Ml 
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Fig.1. S-protein activating capacity of (Nhi”)-RNase S-peptide 1-14 relative to RNase S-peptide l-20 at pH 5.0, 25°C; substrate 
yeast RNA (0.075% in 0.1 M NaOAc); S-protein concentration 5 X lo-’ M. 
229 
Volume 68, number 2 FEBS LETTERS October 1976 
When (Nhi’*)- and (I&i’*, Iler3)-RNase S-peptide 
1-14, the last one having a low binding capacity, 
are mixed with S-protein (5 X 10F8 M) in a molar 
ratio of 2000:80: 1 respectively, no decrease in 
activity is observed in comparison with the activity 
measured (Q 50%) when the Hhi-analogue is com- 
bined with S-protein under the same conditions (i.e. 
close to 50% S-protein saturation). This indicates that 
neither the L- nor the D-imidazolylglycine’*-S-peptide 
acts as an inhibitor. The approximate association con- 
stant and the activity of the (Nhi’*)-RNase S’ complex 
are given in table 1. They were estimated from a 
double reciprocal plot of the activity measured at a 
given peptide concentration versus the total concen- 
tration of the activating peptide, using the graphical 
method of Berger and Levit [ 10,l l] . In spite of the 
relatively low pKp of 4.6 [6] and the shortened side 
chain of the Nhi-12 residue a considerable enzymatic 
activity can be reached, although the binding capa- 
city of this S-peptide analogue is lowered by a factor 
of approximately 10’ in comparison with the natural 
Speptide l-20. 
Shortening or lengthening the side chain of His-l 2 
seems to have a strong effect on the association con- 
stant of the RNase S’ complex in the presence of 
yeast RNA as a substrate [ 131. Adhering - by way 
of simplification - to the traditional picture of 
enzymatic reactions one would describe the results 
obtained by saying that the S-protein/S-peptide/ 
substrate complex has a somewhat higher free enthalpy 
in the case of the Nhi- and the Hhi-peptide than with 
the natural His-l 2 peptide. Remarkably the rate of 
the chemical reaction proper is similar in the three 
cases. Presumably the position and orientation of the 
reacting nitrogen atom (tele-N?) of the Hhi-I 2 and 
the Nhi-12 residue in the complex does not significantly 
differ from that of the tele-N of His-l 2 in the normal 
RNase S’. It is not difficult to envisage that this may 
Table 1 
Activities (A max) and binding constants (Kb) of some 
RNase S’ complexes, using yeast RNA as a substrate 
Analogue 
S-peptide l-20 
S-peptide 1- 14 
(Hhi-12) 1-14 
(Nhi-12) 1-14 
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A max (%) 
100 
80 
70 
80 * 20 
Kb (M-r) 
2.5 x 10s 
5x 10s 
2.5 X lo6 
1.5 (* 0.5) x 10s 
go with a lesser fit elsewhere in the complex. 
Evidently the differences in pK$ of the Nhi, the 
Hhi and the His residue are not large enough to have 
a strong effect on the reaction rate. Moreover the 
differences in basicity will be partly compensated by 
the differences in degree of dissociation. It seems 
highly informative to study the pH dependency curves 
of the three ribonuclease S’ complexes. 
For the future one has to reckon with the now 
disclosed possibility that at least in some enzymes 
even amino acid residues that directly react in the 
chemical conversion of the substrate can be appro- 
priately varied without loss of reactivity of the 
enzyme-substrate complex. 
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